Vascular aspects in the pathophysiology of glaucomatous optic neuropathy

被引:157
作者
Chung, HS
Harris, A
Evans, DW
Kagemann, L
Garzozi, HJ
Martin, B
机构
[1] Indiana Univ, Sch Med, Dept Ophthalmol, Glaucoma Res & Diagnost Ctr, Indianapolis, IN 46202 USA
[2] Indiana Univ, Dept Physiol & Biophys, Indianapolis, IN 46202 USA
[3] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA
关键词
autoregulation; Ca2+ channel blocker; intraocular pressure; ischemia; nocturnal ocular blood flow; vasospasm;
D O I
10.1016/S0039-6257(99)00050-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Glaucoma remains a major eye illness with unknown etiology.;Although elevated intraocular pressure is clearly a major risk factor, vascular deficits may contribute to initiation and progression of glaucoma. When intraocular pressure is acutely elevated in healthy individuals, the resistance index (derived from the peak systolic and end-diastolic velocities and an indirect index of vascular resistance distal to the site of measurement) in the central retinal and posterior ciliary arteries increases progressively. This result implies that mechanical and vascular factors may be coupled in such a way that perfusion of the retina and optic nerve head may be influenced by changes in the intraocular pressure. Further, at night, when ophthalmic artery flow velocities fall as arterial blood pressure falls in glaucoma patients, the risk of disease progression may be increased. The constancy of these same flow velocities in age-matched healthy individuals points to a possible vascular autoregulatory defect in glaucoma. In addition, in normal-tension glaucoma, vasodilation (CO, inhalation) normalizes retrobulbar arterial flow velocities, hinting that some vascular deficits in glaucoma may be reversible. Finally, Ca2+ channel blockade improves contrast sensitivity in patients with normal-tension glaucoma, who also show increased retrobulbar vessel flow velocities, a result suggesting that visual function loss may be linked to ocular ischemia. Emerging evidence points to a role of ischemia in the pathogenesis of glaucoma, suggesting that treatments designed to improve ocular blood flow may benefit glaucoma patients. (C) 1999 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:S43 / S50
页数:8
相关论文
共 64 条
[1]   DIURNAL AND NOCTURNAL BLOOD-PRESSURE DROPS IN PATIENTS WITH FOCAL ISCHEMIC GLAUCOMA [J].
BECHTOILLE, A ;
BRESSONDUMONT, H .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1994, 232 (11) :675-679
[2]  
BILL A, 1990, GRAEF ARCH CLIN EXP, V228, P124, DOI 10.1007/BF00935720
[3]   NIMODIPINE, A CENTRALLY ACTIVE CALCIUM-ANTAGONIST, EXERTS A BENEFICIAL EFFECT ON CONTRAST SENSITIVITY IN PATIENTS WITH NORMAL-TENSION GLAUCOMA AND IN CONTROL SUBJECTS [J].
BOSE, S ;
PILTZ, JR ;
BRETON, ME .
OPHTHALMOLOGY, 1995, 102 (08) :1236-1241
[4]  
BressonDumont H, 1996, J FR OPHTALMOL, V19, P435
[5]  
Butt Z, 1997, INVEST OPHTH VIS SCI, V38, P690
[6]  
CARTER CJ, 1990, OPHTHALMOLOGY, V97, P49
[7]  
Cellini M, 1997, ACTA OPHTHALMOL SCAN, V75, P11
[8]  
Chauhan BC, 1995, UPDATE TO GLAUCOMA, OCULAR BLOOD FLOW AND DRUG TREATMENT, P1
[9]  
DOWNING GJ, 1991, J ULTRAS MED, V10, P317
[10]   RESPONSE OF BLOOD-FLOW TO WARM AND COLD IN NORMAL AND LOW-TENSION GLAUCOMA PATIENTS [J].
DRANCE, SM ;
DOUGLAS, GR ;
WIJSMAN, K ;
SCHULZER, M ;
BRITTON, RJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 105 (01) :35-39